Conditions: Arthritis, Juvenile Idiopathic
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 127
Healthy volunteers: no

Brief summary:
This study will evaluate the effect of etanercept on the clinical benefit, safety, and physical functioning (ability to function in daily life) in children and adolescent subjects with 3 subtypes of childhood arthritis.

Detailed description:

Arms:
arm 1: Etanercept 0.8 mg/kg QW up to a maximum dose of 50 mg

Interventions: intervention 1: Etanercept
Intervention descriptions: intervention 1: Etanercept 0.8 mg/kg QW up to a maximum dose of 50 mg

Protocol document: